Filing Details

Accession Number:
0000898432-18-000901
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-08 18:29:32
Reporting Period:
2018-08-06
Accepted Time:
2018-08-08 18:29:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1325618 Iradimed Corp IRMD Surgical & Medical Instruments & Apparatus (3841) 731408526
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1613803 K. Christopher Scott C/O Iradimed Corporation
1025 Willa Springs Dr.
Winter Springs FL 32708
Cfo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-06 26,297 $1.48 32,398 No 4 A Direct
Common Stock Disposition 2018-08-06 26,297 $26.16 6,101 No 4 S Direct
Common Stock Acquisiton 2018-08-07 66,046 $1.48 72,147 No 4 A Direct
Common Stock Disposition 2018-08-07 66,046 $26.03 6,101 No 4 S Direct
Common Stock Acquisiton 2018-08-08 3,907 $1.48 10,008 No 4 A Direct
Common Stock Disposition 2018-08-08 3,907 $25.76 6,101 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 A Direct
No 4 S Direct
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-08-06 26,297 $0.00 26,297 $1.48
Common Stock Stock Option (Right to Buy) Disposition 2018-08-07 66,046 $0.00 66,046 $1.48
Common Stock Stock Option (Right to Buy) Disposition 2018-08-08 3,907 $0.00 3,907 $1.48
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
69,953 2023-12-29 No 4 M Direct
3,907 2023-12-29 No 4 M Direct
0 2023-12-29 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $26.00 to $26.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  2. This transaction was executed in multiple trades at prices ranging from $26.00 to $26.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $25.50 to $26.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This option, representing a right to purchase a total of 96,250 shares, was granted on 12/31/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.